You just read:

More Rheumatologists are Using Pfizer's Xeljanz in Psoriatic Arthritis Patients, Outpacing the Impressive Growth Displayed by Eli Lilly's Taltz in the Previous Quarter

News provided by

Spherix Global Insights

Oct 08, 2018, 16:39 ET